Asset Transfer and License AgreementAssignment and Assumption Agreement • February 18th, 2016 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
This Asset Transfer and License Agreement (the “Agreement”), is entered into as of February 17, 2015 (the “Effective Date”), by and between Revogenex Ireland Limited, an Irish limited company (“Revogenex”), and Coronado Biosciences, Inc., a Delaware corporation (“Coronado”). Coronado and Revogenex are both referred to herein as “Parties” or each individually, as a “Party.”
FIRST AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • February 18th, 2016 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT TO CONSULTING AGREEMENT (this “Amendment”) is made and entered into this 25th day of January, 2016 by and between Scott A. Reines, MD, PhD (“Consultant”) Avenue Therapeutics, Inc. and its affiliates, having offices at 3 Columbus Circle, 15th Floor, New York, NY 10019 (“Avenue”).
